These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30329034)

  • 21. Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
    Sandborn WJ; Baert F; Danese S; Krznarić Ž; Kobayashi T; Yao X; Chen J; Rosario M; Bhatia S; Kisfalvi K; D'Haens G; Vermeire S
    Gastroenterology; 2020 Feb; 158(3):562-572.e12. PubMed ID: 31470005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and treatment responses in pediatric lymphocytic and collagenous colitis.
    Narla NP; Smyrk TC; Pardi DS; Tung J
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):557-61. PubMed ID: 23820404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical course of microscopic colitis in a single-center cohort study.
    Calabrese C; Gionchetti P; Liguori G; Areni A; Fornarini GS; Campieri M; Rizzello F
    J Crohns Colitis; 2011 Jun; 5(3):218-21. PubMed ID: 21575884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.
    Miehlke S; Aust D; Mihaly E; Armerding P; Böhm G; Bonderup O; Fernández-Bañares F; Kupcinskas J; Munck LK; Rehbehn KU; Nacak T; Greinwald R; Münch A;
    Gastroenterology; 2018 Dec; 155(6):1795-1804.e3. PubMed ID: 30195447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile Acid Sequestrant Therapy in Microscopic Colitis.
    Northcutt MJ; Gentile NM; Goldstein JL; Yen EF
    J Clin Gastroenterol; 2022 Feb; 56(2):161-165. PubMed ID: 33443968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An altered composition of the microbiome in microscopic colitis is driven towards the composition in healthy controls by treatment with budesonide.
    Rindom Krogsgaard L; Kristian Munck L; Bytzer P; Wildt S
    Scand J Gastroenterol; 2019 Apr; 54(4):446-452. PubMed ID: 31009268
    [No Abstract]   [Full Text] [Related]  

  • 27. Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.
    Mosli MH; MacDonald JK; Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; Khanna R; Feagan BG
    Inflamm Bowel Dis; 2015 May; 21(5):1151-9. PubMed ID: 25844963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.
    Fernandez-Bañares F; Piqueras M; Guagnozzi D; Robles V; Ruiz-Cerulla A; Casanova MJ; Gisbert JP; Busquets D; Arguedas Y; Pérez-Aisa A; Fernández-Salazar L; Lucendo AJ;
    Dig Liver Dis; 2017 Sep; 49(9):973-977. PubMed ID: 28457904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
    Münch A; Bohr J; Miehlke S; Benoni C; Olesen M; Öst Å; Strandberg L; Hellström PM; Hertervig E; Armerding P; Stehlik J; Lindberg G; Björk J; Lapidus A; Löfberg R; Bonderup O; Avnström S; Rössle M; Dilger K; Mueller R; Greinwald R; Tysk C; Ström M;
    Gut; 2016 Jan; 65(1):47-56. PubMed ID: 25425655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.
    Abu-Sbeih H; Ali FS; Alsaadi D; Jennings J; Luo W; Gong Z; Richards DM; Charabaty A; Wang Y
    J Immunother Cancer; 2018 Dec; 6(1):142. PubMed ID: 30518410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and Management of Microscopic Colitis.
    Pardi DS
    Am J Gastroenterol; 2017 Jan; 112(1):78-85. PubMed ID: 27897155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
    Bergqvist V; Hertervig E; Gedeon P; Kopljar M; Griph H; Kinhult S; Carneiro A; Marsal J
    Cancer Immunol Immunother; 2017 May; 66(5):581-592. PubMed ID: 28204866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report: Pentoxifylline treatment in microscopic colitis.
    Cotter TG; Kamboj AK; Hicks SB; Tremaine WJ; Loftus EV; Pardi DS
    Medicine (Baltimore); 2017 Nov; 96(46):e8355. PubMed ID: 29145246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
    Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
    Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking Status Influences Clinical Outcome in Collagenous Colitis.
    Münch A; Tysk C; Bohr J; Madisch A; Bonderup OK; Mohrbacher R; Mueller R; Greinwald R; Ström M; Miehlke S
    J Crohns Colitis; 2016 Apr; 10(4):449-54. PubMed ID: 26721941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
    Boden EK; Shows DM; Chiorean MV; Lord JD
    Dig Dis Sci; 2018 Sep; 63(9):2419-2429. PubMed ID: 29372476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Locally acting corticosteroids in microscopic colitis: are they the treatment of choice? How should they be used?].
    Marín-Jiménez I; Yepes Barreto I
    Gastroenterol Hepatol; 2008 Sep; 31 Suppl 3():22-6. PubMed ID: 19087860
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.
    Amiot A; Grimaud JC; Peyrin-Biroulet L; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Moreau J; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Bouhnik Y; ;
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1593-1601.e2. PubMed ID: 26917043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease.
    Singh N; Rabizadeh S; Jossen J; Pittman N; Check M; Hashemi G; Phan BL; Hyams JS; Dubinsky MC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2121-6. PubMed ID: 27542130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of budesonide in collagenous colitis Evaluation of: Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146(5):1222-1230 e1222.
    Drug VL; Antoniu SA
    Expert Opin Pharmacother; 2014 Oct; 15(15):2277-9. PubMed ID: 25164577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.